← Back to Search

Genotyping Intervention Supportive Care for Chemotherapy

N/A
Waitlist Available
Led By Rhonda Cooper-DeHoff, Pharm D, MS
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at pre-chemotherapy (baseline), 2 weeks, 4 weeks, and 12 weeks post initiation of chemotherapy.
Awards & highlights

Study Summary

This trial is testing whether using a patient's genetic profile to guide which supportive care medications they take during chemotherapy results in fewer side effects and less overall distress.

Eligible Conditions
  • Chemotherapy
  • Supportive Care
  • Genotyping

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at pre-chemotherapy (baseline), 2 weeks, 4 weeks, and 12 weeks post initiation of chemotherapy.
This trial's timeline: 3 weeks for screening, Varies for treatment, and at pre-chemotherapy (baseline), 2 weeks, 4 weeks, and 12 weeks post initiation of chemotherapy. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in patient MDASI scoring
Secondary outcome measures
Pharmaceutical Preparations

Trial Design

2Treatment groups
Active Control
Group I: Genotyping Intervention Supportive CareActive Control1 Intervention
For those randomized to the genotype intervention group, genotype results will be returned in the EHR pre-emptively and supportive care will be prescribed based on genotype results.
Group II: Delayed Genotyping Intervention Supportive CareActive Control1 Intervention
For those randomized to the delayed genotype intervention group, supportive care will be prescribed based on usual clinical practice.

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,340 Previous Clinical Trials
715,557 Total Patients Enrolled
Rhonda Cooper-DeHoff, Pharm D, MSPrincipal InvestigatorUniversity of Florida

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this investigation currently recruiting participants?

"According to clinicaltrials.gov, the initial posting for this medical trial was on July 9th 2019 and it's most recent update happened on August 9th 2022. Unfortunately, patient recruitment is not currently open; however, there are 42 other trials actively seeking participants as of now."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Genotype-guided Supportive Care in Symptom Treatment of Cancer Patients
2019. "Genotype-guided Supportive Care in Symptom Treatment of Cancer Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03924557.
~26 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top